NIA SBIR-FUNDED JUVENA THERAPEUTICS TRANSLATION OF POWERFUL PROTEINS INTO TRANSFORMATIVE THERAPEUTICS
Jeremy O’Connell · 2024
Read NIA SBIR-FUNDED JUVENA THERAPEUTICS TRANSLATION OF POWERFUL PROTEINS INTO TRANSFORMATIVE THERAPEUTICS by Jeremy O’Connell (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11688835.txt.
Description
Jeremy O'Connell profiles a young drug company, Juvena Therapeutics, in a 2024 showcase piece on small business research funding. The company was founded to restore tissue health by fixing protein signals between cells. It received backing in 2021 from a federal small business program run by the National Institute on Aging.
Juvena maps proteins that stem cells release, screens them with an AI-enabled platform, and engineers the best finds into biologic medicines. The grant paid to polish its lead compound, widen its screens, and gain strict peer review feedback. Since then the company has raised close to sixty million dollars in venture funding. The piece holds the firm up as an example of how early public grants can carry a biotech startup toward private money and real products.
Catalog record
| CREATOR | Jeremy O’Connell |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 1 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |